These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20113171)

  • 1. Characterization, in vitro cytotoxicity and cellular accumulation of paclitaxel-loaded lipid nano-emulsions.
    Takegami S; Takara K; Tanaka S; Yamamoto K; Hori M; Yokoyama T; Kitade T
    J Microencapsul; 2010; 27(5):453-9. PubMed ID: 20113171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.
    Lee MK; Lim SJ; Kim CK
    Biomaterials; 2007 Apr; 28(12):2137-46. PubMed ID: 17257668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis.
    Nornoo AO; Osborne DW; Chow DS
    Int J Pharm; 2008 Feb; 349(1-2):108-16. PubMed ID: 17869459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes.
    Niu R; Zhao P; Wang H; Yu M; Cao S; Zhang F; Chang J
    J Drug Target; 2011 Jun; 19(5):373-81. PubMed ID: 20677917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
    Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
    J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A folate receptor-targeted emulsion formulation for paclitaxel.
    Stevens PJ; Lee RJ
    Anticancer Res; 2003; 23(6C):4927-31. PubMed ID: 14981947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
    Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
    J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tocopheryl succinate-based lipid nanospheres for paclitaxel delivery: preparation, characters, and in vitro release kinetics.
    Shi K; Jiang Y; Zhang M; Wang Y; Cui F
    Drug Deliv; 2010 Jan; 17(1):1-10. PubMed ID: 19941405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique.
    Pandita D; Ahuja A; Velpandian T; Lather V; Dutta T; Khar RK
    Pharmazie; 2009 May; 64(5):301-10. PubMed ID: 19530440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery.
    Shahin M; Lavasanifar A
    Int J Pharm; 2010 Apr; 389(1-2):213-22. PubMed ID: 20080163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro cytotoxic activity of cationic paclitaxel nanoparticles on MDR-3T3 cells.
    Niu G; Castro CH; Nguyen N; Sullivan SM; Hughes JA
    J Drug Target; 2010 Jul; 18(6):468-76. PubMed ID: 20059301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
    Roger E; Lagarce F; Garcion E; Benoit JP
    J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of propolis extract on sensitivity to chemotherapeutic agents in HeLa and resistant sublines.
    Takara K; Fujita M; Matsubara M; Minegaki T; Kitada N; Ohnishi N; Yokoyama T
    Phytother Res; 2007 Sep; 21(9):841-6. PubMed ID: 17486684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and characterization of antitumor drug paclitaxel-loaded chitosan nanoparticles by W/O emulsions.
    Xu J; Ma L; Liu Y; Xu F; Nie J; Ma G
    Int J Biol Macromol; 2012 Mar; 50(2):438-43. PubMed ID: 22230611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models.
    Zou Y; Fu H; Ghosh S; Farquhar D; Klostergaard J
    Clin Cancer Res; 2004 Nov; 10(21):7382-91. PubMed ID: 15534115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactose-grafted chylomicron-mimicking emulsion: evaluation of specificity against HepG-2 and MCF-7 cell lines.
    Jain V; Nath B; Gupta GK; Shah PP; Siddiqui MA; Pant AB; Mishra PR
    J Pharm Pharmacol; 2009 Mar; 61(3):303-10. PubMed ID: 19222902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphology and in vitro release kinetics of drug-loaded micelles based on well-defined PMPC-b-PBMA copolymer.
    Chu H; Liu N; Wang X; Jiao Z; Chen Z
    Int J Pharm; 2009 Apr; 371(1-2):190-6. PubMed ID: 19162151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.